Overview

Geodon in Weight Loss Study for Bipolar Disorders

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This research study is designed to determine if replacing your current antipsychotic and/or mood stabilizer with ziprasidone (Geodon) will impact weight. This research is being conducted because Geodon has a documented effect on mood. Additionally, we believe Geodon to be an effective medication for overweight or obese patients with bipolar disorder. There will be approximately 25 patients enrolled in this study.
Phase:
Phase 4
Details
Lead Sponsor:
Stanford University
Collaborator:
Pfizer
Treatments:
Ziprasidone